Cancer stem cells and cancer therapy (Q37841186)

24 August 2017

1 reference

title

Cancer stem cells and cancer therapy (English)

1 reference

24 August 2017

main subject

neoplastic stem cells

1 reference

Sara Soltanian

1

1 reference

24 August 2017

Maryam M Matin

series ordinal

2

1 reference

24 August 2017

publication date

12 February 2011

1 reference

24 August 2017

1 reference

24 August 2017

volume

32

1 reference

24 August 2017

issue

3

1 reference

24 August 2017

page(s)

425-440

1 reference

Stem cells, cancer, and cancer stem cells

24 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS13277-011-0155-8

Stem-cell origin of metastasis and heterogeneity in solid tumours

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-011-0155-8

Normal and leukemic hematopoiesis: Are leukemias a stem cell disorder or a reacquisition of stem cell characteristics?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-011-0155-8

The biology of cancer stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-011-0155-8

Stem cell origin of cancer and differentiation therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-011-0155-8

A cell initiating human acute myeloid leukaemia after transplantation into SCID mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-011-0155-8

Prospective identification of tumorigenic breast cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-011-0155-8

Identification of human brain tumour initiating cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-011-0155-8

Identification of pancreatic cancer stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-011-0155-8

Identification of a subpopulation of cells with cancer stem cell properties in head and neck squamous cell carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-011-0155-8

Identification of cells initiating human melanomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-011-0155-8

Significance of CD90+ cancer stem cells in human liver cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-011-0155-8

Identification of cancer stem cells in Ewing's sarcoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-011-0155-8

Human melanoma-initiating cells express neural crest nerve growth factor receptor CD271

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-011-0155-8

Prognostic significance of tumorigenic cells with mesenchymal features in pancreatic adenocarcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-011-0155-8

Efficient tumour formation by single human melanoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-011-0155-8

Tumor-initiating cells are rare in many human tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-011-0155-8

Human acute myeloid leukemia is organized as a hierarchy that originates from a primitive hematopoietic cell

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-011-0155-8

Identification of bronchioalveolar stem cells in normal lung and lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-011-0155-8

Highly purified CD44+ prostate cancer cells from xenograft human tumors are enriched in tumorigenic and metastatic progenitor cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-011-0155-8

Prospective identification of tumorigenic prostate cancer stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-011-0155-8

Ovarian cancer side population defines cells with stem cell-like characteristics and Mullerian Inhibiting Substance responsiveness

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-011-0155-8

A human colon cancer cell capable of initiating tumour growth in immunodeficient mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-011-0155-8

Identification and expansion of human colon-cancer-initiating cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-011-0155-8

Self-renewal, multipotency, and the existence of two cell populations within an epithelial stem cell niche

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-011-0155-8

Embryonic stem (ES) cells and embryonal carcinoma (EC) cells: opposite sides of the same coin.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-011-0155-8

Applying the principles of stem-cell biology to cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-011-0155-8

Bmi-1 determines the proliferative capacity of normal and leukaemic stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-011-0155-8

Tissue repair and stem cell renewal in carcinogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-011-0155-8

Therapeutic implications of cancer stem cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-011-0155-8

Tumour stem cells and drug resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-011-0155-8

Cancer stem cells and chemoradiation resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-011-0155-8

Telomeres and telomerase in hematologic neoplasia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-011-0155-8

Telomeres and telomerase in stem cells during aging and disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-011-0155-8

A POU-domain transcription factor in early stem cells and germ cells of the mammalian embryo

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-011-0155-8

Signalling, cell cycle and pluripotency in embryonic stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-011-0155-8

Regulatory networks in embryo-derived pluripotent stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-011-0155-8

Specific knockdown of Oct4 and beta2-microglobulin expression by RNA interference in human embryonic stem cells and embryonic carcinoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-011-0155-8

Isolation and in vitro propagation of tumorigenic breast cancer cells with stem/progenitor cell properties

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-011-0155-8

Oct-4 expression maintained cancer stem-like properties in lung cancer-derived CD133-positive cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-011-0155-8

Embryonic stem cell markers expression in cancers.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-011-0155-8

Multidrug resistance in cancer: role of ATP-dependent transporters

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-011-0155-8

The ABC transporter Bcrp1/ABCG2 is expressed in a wide variety of stem cells and is a molecular determinant of the side-population phenotype

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-011-0155-8

Glioma stem cells promote radioresistance by preferential activation of the DNA damage response

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-011-0155-8

Association of reactive oxygen species levels and radioresistance in cancer stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-011-0155-8

Resistance to chemotherapy: new treatments and novel insights into an old problem

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-011-0155-8

Stem cells: a new lease on life

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-011-0155-8

A genetic determinant that specifically regulates the frequency of hematopoietic stem cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-011-0155-8

Normal stem cells and cancer stem cells: similar and different

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-011-0155-8

A role for Wnt signalling in self-renewal of haematopoietic stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-011-0155-8

Expression of BCR/ABL and BCL-2 in myeloid progenitors leads to myeloid leukemias

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-011-0155-8

Spontaneous transformation of human adult nontumorigenic stem cells to cancer stem cells is driven by genomic instability in a human model of glioblastoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-011-0155-8

BRCA1 basal-like breast cancers originate from luminal epithelial progenitors and not from basal stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-011-0155-8

Non-stem cell origin for oligodendroglioma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-011-0155-8

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-011-0155-8

New hope for cancer treatment: exploring the distinction between normal adult stem cells and cancer stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-011-0155-8

Pten dependence distinguishes haematopoietic stem cells from leukaemia-initiating cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-011-0155-8

PTEN-deficient intestinal stem cells initiate intestinal polyposis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-011-0155-8

Bmi-1 is required for maintenance of adult self-renewing haematopoietic stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-011-0155-8

Bmi-1 promotes neural stem cell self-renewal and neural development but not mouse growth and survival by repressing the p16Ink4a and p19Arf senescence pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-011-0155-8

Cancer stem cells: the theory and perspectives in cancer therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-011-0155-8

Wnt signaling and the regulation of stem cell function

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-011-0155-8

Wnt signalling in stem cells and cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-011-0155-8

Cutaneous cancer stem cell maintenance is dependent on beta-catenin signalling

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-011-0155-8

β-Catenin mediates the establishment and drug resistance of MLL leukemic stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-011-0155-8

Hedgehog signaling in animal development: paradigms and principles

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-011-0155-8

Mapping sonic hedgehog-receptor interactions by steric interference

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-011-0155-8

Sonic hedgehog signaling by the patched-smoothened receptor complex

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-011-0155-8

Vertebrate Smoothened functions at the primary cilium

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-011-0155-8

Hedgehog signalling in cancer formation and maintenance

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-011-0155-8

Hedgehog signalling as a target in cancer stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-011-0155-8

Notch signaling: cell fate control and signal integration in development

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-011-0155-8

Notch signalling: a simple pathway becomes complex

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-011-0155-8

The Hedgehog and Wnt signalling pathways in cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-011-0155-8

The role of Notch in tumorigenesis: oncogene or tumour suppressor?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-011-0155-8

Loss of NOTCH2 positively predicts survival in subgroups of human glial brain tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-011-0155-8

Gain-of-function mutations and copy number increases of Notch2 in diffuse large B-cell lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-011-0155-8

Notch signaling in glioblastoma: a developmental drug target?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-011-0155-8

Purification and characterization of mouse hematopoietic stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-011-0155-8

Purification of primitive human hematopoietic cells capable of repopulating immune-deficient mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-011-0155-8

Differential long-term and multilineage engraftment potential from subfractions of human CD34+ cord blood cells transplanted into NOD/SCID mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-011-0155-8

Identification of long-term repopulating potential of human cord blood-derived CD34-flt3- severe combined immunodeficiency-repopulating cells by intra-bone marrow injection

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-011-0155-8

Leukemia-initiating cells from some acute myeloid leukemia patients with mutated nucleophosmin reside in the CD34(-) fraction

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-011-0155-8

Identification and targeting of cancer stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-011-0155-8

Identification and characterization of tumorigenic liver cancer stem/progenitor cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-011-0155-8

Identification and expansion of the tumorigenic lung cancer stem cell population

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-011-0155-8

Characterization of a subpopulation of colon cancer cells with stem cell-like properties

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-011-0155-8

Identification of cancer stem cell-like cells from human epithelial ovarian carcinoma cell line

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-011-0155-8

Epigenetic regulation of CD133 and tumorigenicity of CD133+ ovarian cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-011-0155-8

Stem cells in normal breast development and breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-011-0155-8

ALDH1 is a marker of normal and malignant human mammary stem cells and a predictor of poor clinical outcome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-011-0155-8

Aldehyde dehydrogenase 1 is a marker for normal and malignant human colonic stem cells (SC) and tracks SC overpopulation during colon tumorigenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-011-0155-8

Aldehyde dehydrogenase 1 A1-positive cell population is enriched in tumor-initiating cells and associated with progression of bladder cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-011-0155-8

Differential expression of aldehyde dehydrogenase 1a1 (ALDH1) in normal ovary and serous ovarian tumors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-011-0155-8

CD133(+) and CD133(-) glioblastoma-derived cancer stem cells show differential growth characteristics and molecular profiles

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-011-0155-8

Clinical and biological implications of CD133-positive and CD133-negative cells in glioblastomas.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-011-0155-8

Recent advances in cancer stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-011-0155-8

The cancer stem cell hypothesis: a work in progress

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-011-0155-8

Membrane transporters and channels: role of the transportome in cancer chemosensitivity and chemoresistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-011-0155-8

Multidrug resistance transporters and modulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-011-0155-8

Accumulation of CD133-positive glioma cells after high-dose irradiation by Gamma Knife surgery plus external beam radiation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-011-0155-8

BMI1 Confers Radioresistance to Normal and Cancerous Neural Stem Cells through Recruitment of the DNA Damage Response Machinery

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-011-0155-8

Molecular mechanisms of mammalian DNA repair and the DNA damage checkpoints

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-011-0155-8

Comparative analysis of DNA repair in stem and nonstem glioma cell cultures

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-011-0155-8

Cell-cycle restriction limits DNA damage and maintains self-renewal of leukaemia stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-011-0155-8

The DNA damage response: putting checkpoints in perspective

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-011-0155-8

Targeting cancer cells by ROS-mediated mechanisms: a radical therapeutic approach?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-011-0155-8

Breast cancer stem cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-011-0155-8

Tumour stem cell-targeted treatment: elimination or differentiation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-011-0155-8

Targeting cancer stem cells in cancer prevention and therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-011-0155-8

Cancer stem cells--old concepts, new insights.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-011-0155-8

21 January 2018

Differentiation therapy

1 reference

https://api.crossref.org/works/10.1007%2FS13277-011-0155-8

Differentiation therapy exerts antitumor effects on stem-like glioma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-011-0155-8

Treatment of acute promyelocytic leukemia: strategy toward further increase of cure rate

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-011-0155-8

Retinoids: potential in cancer prevention and therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-011-0155-8

The effects of histone deacetylase inhibitors on heterochromatin: implications for anticancer therapy?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-011-0155-8

The histone deacetylase inhibitor SAHA arrests cancer cell growth, up-regulates thioredoxin-binding protein-2, and down-regulates thioredoxin.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-011-0155-8

Bone morphogenetic proteins inhibit the tumorigenic potential of human brain tumour-initiating cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-011-0155-8

Delivering cancer stem cell therapies - a role for nanomedicines?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-011-0155-8

Identification of selective inhibitors of cancer stem cells by high-throughput screening

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-011-0155-8

The cancer stem cell selective inhibitor salinomycin is a p-glycoprotein inhibitor.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-011-0155-8

Inhibition of the multidrug resistance P-glycoprotein activity by green tea polyphenols

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-011-0155-8

Role of glutathione S-transferase P1, P-glycoprotein and multidrug resistance-associated protein 1 in acquired doxorubicin resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-011-0155-8

The inhibition of the estrogenic effects of pesticides and environmental chemicals by curcumin and isoflavonoids

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-011-0155-8

Mogoltacin enhances vincristine cytotoxicity in human transitional cell carcinoma (TCC) cell line

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-011-0155-8

The enhancement of vincristine cytotoxicity by combination with feselol

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-011-0155-8

Phase II study of ET-743 in advanced soft tissue sarcomas: a European Organisation for the Research and Treatment of Cancer (EORTC) soft tissue and bone sarcoma group trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-011-0155-8

Targeting multidrug resistance in cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-011-0155-8

Nuclear factor-kappaB is constitutively activated in primitive human acute myelogenous leukemia cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-011-0155-8

Transcription factor NF-κB inhibitors as single therapeutic agents or in combination with classical chemotherapeutic agents for the treatment of hematologic malignancies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-011-0155-8

The CD44 receptor interacts with P-glycoprotein to promote cell migration and invasion in cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-011-0155-8

Targeting of CD44 eradicates human acute myeloid leukemic stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-011-0155-8

Elevated expression of IL-3Ralpha in acute myelogenous leukemia is associated with enhanced blast proliferation, increased cellularity, and poor prognosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-011-0155-8

Expression and prognostic value of hemopoietic cytokine receptors in acute myeloid leukemia (AML): implications for future therapeutical strategies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-011-0155-8

Monoclonal antibody-mediated targeting of CD123, IL-3 receptor alpha chain, eliminates human acute myeloid leukemic stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-011-0155-8

Cellular signaling in normal and cancerous stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-011-0155-8

BMPs signal alternately through a SMAD or FRAP-STAT pathway to regulate fate choice in CNS stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-011-0155-8

Antitumor activity of rapamycin in a Phase I trial for patients with recurrent PTEN-deficient glioblastoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-011-0155-8

Teratogen-mediated inhibition of target tissue response to Shh signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-011-0155-8

Medulloblastoma growth inhibition by hedgehog pathway blockade

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-011-0155-8

Hedgehog signaling and Bmi-1 regulate self-renewal of normal and malignant human mammary stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-011-0155-8

Hedgehog signaling maintains a tumor stem cell compartment in multiple myeloma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-011-0155-8

Notch signaling, gamma-secretase inhibitors, and cancer therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-011-0155-8

Regulation of breast cancer stem cell activity by signaling through the Notch4 receptor.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-011-0155-8

Targeting breast cancer stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-011-0155-8

Resveratrol in cardioprotection: a therapeutic promise of alternative medicine

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-011-0155-8

Resveratrol-induced apoptosis in human T-cell acute lymphoblastic leukaemia MOLT-4 cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-011-0155-8

Combination therapy targeting both tumor-initiating and differentiated cell populations in prostate carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-011-0155-8

Expression profiling of CD34+ hematopoietic stem/ progenitor cells reveals distinct subtypes of therapy-related acute myeloid leukemia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-011-0155-8

In vivo dynamics of human cord blood-derived CD34(-) SCID-repopulating cells using intra-bone marrow injection

21 January 2018

1 reference

12 December 2020

Anti-CD38 antibody-mediated clearance of human repopulating cells masks the heterogeneity of leukemia-initiating cells

1 reference

12 December 2020

Role of resveratrol in prevention and therapy of cancer: preclinical and clinical studies.

1 reference

12 December 2020

Tumor growth need not be driven by rare cancer stem cells

1 reference

12 December 2020

CD133 expression is not restricted to stem cells, and both CD133+ and CD133- metastatic colon cancer cells initiate tumors

1 reference

12 December 2020

CD133 is a temporary marker of cancer stem cells in small cell lung cancer, but not in non-small cell lung cancer

1 reference

12 December 2020

Cytotoxicity of vincristine on the 5637 cell line is enhanced by combination with conferone

1 reference

12 December 2020

Notch signaling in gastrointestinal tract (review).

1 reference

12 December 2020

The ABCs of cancer stem cell drug resistance

1 reference

12 December 2020

Maturation arrest of stem cell differentiation is a common pathway for the cellular origin of teratocarcinomas and epithelial cancers.

1 reference

12 December 2020

Differences between the CD34+ and CD34- blast compartments in apoptosis resistance in acute myeloid leukemia

1 reference

12 December 2020

Cell-cell signaling through NOTCH regulates human embryonic stem cell proliferation

1 reference

12 December 2020

Identification of a cancer stem cell in human brain tumors

1 reference

12 December 2020

Aberrant marker expression patterns on the CD34+CD38- stem cell compartment in acute myeloid leukemia allows to distinguish the malignant from the normal stem cell compartment both at diagnosis and in remission

1 reference

12 December 2020

Cancer stem cells--normal stem cells "Jedi" that went over to the "dark side".

1 reference

12 December 2020

Identification of therapeutic targets for quiescent, chemotherapy-resistant human leukemia stem cells

1 reference

12 December 2020

Involvement of follicular stem cells in forming not only the follicle but also the epidermis

1 reference

12 December 2020

Identification of human chronic myelogenous leukemia progenitor cells with hemangioblastic characteristics

1 reference

12 December 2020

Oncogenes and tumor suppressor genes as paradigms in oncogenesis

1 reference

12 December 2020

Heredity and cancer in man.

1 reference

12 December 2020

AS602868, a dual inhibitor of IKK2 and FLT3 to target AML cells

1 reference

12 December 2020

Fluorouracil selectively spares acute myeloid leukemia cells with long-term growth abilities in immunodeficient mice and in culture

1 reference

12 December 2020

Vitamin D and the regulation of Wnt/beta-catenin signaling and innate immunity in colorectal cancer

1 reference

12 December 2020

10.1007/S13277-011-0155-8

Identifiers

DOI

1 reference

24 August 2017

1 reference